BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12458911)

  • 21. Developmental immunotoxicity of chemicals in rodents and its possible regulatory impact.
    Hessel EV; Tonk EC; Bos PM; van Loveren H; Piersma AH
    Crit Rev Toxicol; 2015 Jan; 45(1):68-82. PubMed ID: 25372701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress and diverse effects in developmental immunotoxicology: overview of a symposium at the 46th Annual SOT Meeting, Charlotte, NC.
    Rooney AA; Yang Y; Makris SL
    J Immunotoxicol; 2008 Oct; 5(4):395-400. PubMed ID: 19404873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development immunotoxicology and risk assessment. Conclusions and future directions: a personal view from the session chair.
    Dayan AD
    Hum Exp Toxicol; 2002; 21(9-10):569-72. PubMed ID: 12458915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A detailed study of developmental immunotoxicity of imidacloprid in Wistar rats.
    Gawade L; Dadarkar SS; Husain R; Gatne M
    Food Chem Toxicol; 2013 Jan; 51():61-70. PubMed ID: 23000444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental immunotoxicology: focus on health risks.
    Dietert RR
    Chem Res Toxicol; 2009 Jan; 22(1):17-23. PubMed ID: 18783253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotoxicity: hazard identification and risk assessment.
    Luster MI; Kimber I
    Hum Exp Toxicol; 1996 Dec; 15(12):947-8. PubMed ID: 8981097
    [No Abstract]   [Full Text] [Related]  

  • 27. Developmental immunotoxicity of methylmercury: the relative sensitivity of developmental and immune parameters.
    Tonk EC; de Groot DM; Penninks AH; Waalkens-Berendsen ID; Wolterbeek AP; Slob W; Piersma AH; van Loveren H
    Toxicol Sci; 2010 Oct; 117(2):325-35. PubMed ID: 20660081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal immunotoxicant exposure and postnatal autoimmune disease.
    Holladay SD
    Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):687-91. PubMed ID: 10502532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The underestimated value of OECD 421 and 422 repro screening studies: putting it in the right perspective.
    Beekhuijzen M; de Raaf MA; Zmarowski A; van Otterdijk F; Peter B; Emmen H
    Reprod Toxicol; 2014 Sep; 48():81-7. PubMed ID: 24768663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental immunotoxicity (DIT): assays for evaluating effects of exogenous agents on development of the immune system.
    DeWitt JC; Peden-Adams MM; Keil DE; Dietert RR
    Curr Protoc Toxicol; 2012 Feb; Chapter 18():Unit 18.15. PubMed ID: 22511116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicopathology of the developing immune system: investigative and development strategies.
    Weinstock D; Lewis DB; Parker GA; Beyer J; Collinge M; Brown TP; Dybdal N
    Toxicol Pathol; 2010 Dec; 38(7):1111-7. PubMed ID: 20962107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests.
    Luster MI; Portier C; Pait DG; White KL; Gennings C; Munson AE; Rosenthal GJ
    Fundam Appl Toxicol; 1992 Feb; 18(2):200-10. PubMed ID: 1534777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental and reproductive toxicity testing of vaccines.
    Barrow P
    J Pharmacol Toxicol Methods; 2012 Mar; 65(2):58-63. PubMed ID: 22233769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. US FDA "Redbook II" immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins.
    Hinton DM
    Toxicol Pathol; 2000; 28(3):467-78. PubMed ID: 10862567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests.
    Luster MI; Portier C; Pait DG; Rosenthal GJ; Germolec DR; Corsini E; Blaylock BL; Pollock P; Kouchi Y; Craig W
    Fundam Appl Toxicol; 1993 Jul; 21(1):71-82. PubMed ID: 8365588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.
    Dietert RR
    J Immunotoxicol; 2008 Oct; 5(4):401-12. PubMed ID: 19404874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal and early life stress effects on immune function: relevance to immunotoxicology.
    Bellinger DL; Lubahn C; Lorton D
    J Immunotoxicol; 2008 Oct; 5(4):419-44. PubMed ID: 19404876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches to the evaluation of chemical-induced immunotoxicity.
    Krzystyniak K; Tryphonas H; Fournier M
    Environ Health Perspect; 1995 Dec; 103 Suppl 9(Suppl 9):17-22. PubMed ID: 8635435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental immunotoxicity testing: a review.
    Holsapple MP
    Toxicology; 2003 Apr; 185(3):193-203. PubMed ID: 12581694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonhuman primates as animal models for toxicology research.
    Burbacher TM; Grant KS
    Curr Protoc Toxicol; 2001; Chapter 1():Unit1.1. PubMed ID: 23045019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.